Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

A survey on secondary neoplasm post CART

Retrospective Studies

GoCART Coalition

Type of treatment

Principal investigator

Impact of prior B-cell directed immunotherapy (BCDI) on the outcome of CD19 CAR-T cell therapy in aggressive B-cell malignancies, on behalf of the GoCART Coalition initiative.

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

GoCART Coalition

Type of treatment

Principal investigator

Impact de l’immunothérapie dirigée contre les cellules B (BCDI) préalable sur les résultats de la thérapie par cellules CAR-T CD19 dans les malignités agressives des cellules B, au nom de l'initiative GoCART Coalition.

Études rétrospectives

Lymphome non hodgkinien (LNH)

GoCART Coalition

Type of treatment

Principal investigator

The role of bridging therapy before CAR-T cell therapy in diffuse large B-cell lymphoma (DLBCL): An analysis of the LWP of the EBMT and the GoCART coalition.

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

GoCART Coalition

Type of treatment

Principal investigator

Philipp Berning

Rôle de la thérapie de transition avant la thérapie par cellules CAR-T dans le lymphome diffus à grandes cellules B (DLBCL) : une analyse du LWP de l'EBMT et de la coalition GoCART.

Études rétrospectives

Lymphome non hodgkinien (LNH)

GoCART Coalition

Type of treatment

Principal investigator

Philipp Berning

CAR-T in elderly patients

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of treatment

Principal investigator

Vanderson Rocha

Maribavir use for CMV infection in allogeneic stem cell transplantation: the real-world experience. A retrospective study of IDWP EBMT

Retrospective Studies

Complications: infectious

Infectious Diseases Working Party (IDWP)

Type of treatment

Principal investigator

Annalisa Paviglianiti

Utilisation du maribavir pour l'infection à CMV après une allogreffe de cellules souches : l'expérience en vie réelle. Une étude rétrospective de l'IDWP-EBMT.

Études rétrospectives

Complications : infectieuses

Infectious Diseases Working Party (IDWP)

Type of treatment

Principal investigator

Annalisa Paviglianiti

Disease-specificity effects of HLA mismatching effects in unrelated HCT under with PTCy-based GvHD prophylaxis

Retrospective Studies

Acute Lymphatic Leukaemia (ALL)

Acute Myeloid Leukaemia (AML)

Chronic Lymphocytic Leukaemia (CLL)

Chronic Myeloid Lymphoma (CML)

Chronic Lymphocytic Leukaemia (CLL)

Myelodysplastic (MDS) or MDS/MPN

Other myeloid or lymphoid malignancies

Multiple Myeloma (MM) or other Plasma Cell Disorder (PCD)

Non-Hodgkin’s Lymphoma (NHL)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Acute Leukemia Working Party (ALWP)

Type of treatment

Allogeneic - Unrelated

Principal investigator

HLA Mismatch Frequencies in Unrelated Hematopoietic Cell Transplantation

Retrospective Studies

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of treatment

Allogeneic - Unrelated

Principal investigator

Esteban Arrieta Bolaños

Fréquence des incompatibilités HLA dans les greffes de cellules hématopoïétiques à partir de donneurs non apparentés

Études rétrospectives

Toutes les maladies

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of treatment

Allogénique - Non apparentée

Principal investigator

Esteban Arrieta Bolaños

Incidence and outcome of post-transplant haemorrhagic cystitis in patients who undergo allogeneic haematopoietic cell transplantation

Closed Survey/Study

Infectious Diseases Working Party (IDWP)

Type of treatment

Principal investigator